Transaction · 0001536368-26-000008

Kunkel Lori Anne

Kunkel Lori Anne, DIR, reported a transaction classified as exercise at Enliven Therapeutics, Inc. involving 3741.000000 shares for an estimated $4189.92. Reported holdings after the transaction were 45625.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MDIR
ELVNEnliven Therapeutics, Inc.
Disclosed value$4.18kShares × reported price
Shares traded3.74k$1.12 per share
Holdings after45.6kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ELVN price since this filing

Daily closing prices, with the filing date and available return windows
ELVN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.3%1w ago -7.4%1d ago +0.6%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001536368-26-000008
Common Stock
Transaction date
Oct 30, 2026
Filed Nov 03, 2026, 10:21 PM · 4d delay
Shares
3,741 sh
$1.12 per share
Estimated value
$4.18k
Computed from shares × price
Holdings after
45,625 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    All of the shares subject to this option are fully vested and exercisable as of the date hereof.

  2. F2

    The option, originally for 37,882 shares, of which 7,300 shares have been exercised, vests as to 1/36th of the shares on May 8, 2024 and each month thereafter, subject to the Reporting Person continui…

Original filing · 0001536368-26-000008
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ELVN